Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy (Q27658290)

1

0 references

Diane Fournier

2

0 references

Dao-Wei Zhu

3

0 references

Christine Cadot

4

0 references

Donald Poirier

Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolution

5

0 references

language of work or name

English

0 references

publication date

10 December 2009

0 references

published in

Biochemical Journal

0 references

volume

424

0 references

issue

3

0 references

page(s)

357-66

0 references

cites work

1 reference

17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters

21 April 2017

1 reference

The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors

21 April 2017

1 reference

Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+

21 April 2017

1 reference

Cofactor hydrogen bonding onto the protein main chain is conserved in the short chain dehydrogenase/reductase family and contributes to nicotinamide orientation

21 April 2017

1 reference

Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase

21 April 2017

1 reference

Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenase

21 April 2017

1 reference

Coot: model-building tools for molecular graphics

21 April 2017

1 reference

Integrated view on 17beta-hydroxysteroid dehydrogenases

21 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Human Estrogenic 17β-Hydroxysteroid Dehydrogenase: Predominance of Estrone Reduction and Its Induction by NADPH

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Rapid purification yielding highly active 17β-hydroxysteroid dehydrogenase: application of hydrophobic interaction and affinity fast protein liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Short-chain dehydrogenases/reductases (SDR): the 2002 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Coenzyme-based functional assignments of short-chain dehydrogenases/reductases (SDRs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Critical Residues for the Specificity of Cofactors and Substrates in Human Estrogenic 17 -Hydroxysteroid Dehydrogenase 1: Variants Designed from the Three-Dimensional Structure of the Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Control of cell proliferation by steroids: the role of 17HSDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

17 beta-hydroxysteroid dehydrogenases--their role in pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

17Beta-hydroxysteroid dehydrogenase Type 1 and Type 2: association between mRNA expression and activity in cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Endogenous steroids in the pathophysiology of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

New development in intracrinology of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Intracrinology of estrogens and androgens in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Crystal growth of human estrogenic 17beta-hydroxysteroid dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Crystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase complexed with 17 beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

3D-structure of human estrogenic 17β-HSD1: binding with various steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Incorporation of receptor kinetics into a model for bacterial chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Crystallogenesis of Steroid-Converting Enzymes and Their Complexes: Enzyme–Ligand Interaction Studies and Inhibitor Design Facilitated by Complex Structures†

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Pi-pi interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020

Design and synthesis of bisubstrate inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091020